LADAR 6000: good but time consuming

Article

Although the LADAR 6000 (Alcon) is accurate and safe, the need for pharmacological mydriasis and the use of a nomogram result in a more time consuming surgical procedure.

Although the LADAR 6000 (Alcon) is accurate and safe, the need for pharmacological mydriasis and the use of a nomogram result in a more time consuming surgical procedure, according to Joaquim Murta and colleagues from Coimbra University, Portugal.

A total of 300 consecutive eyes underwent refractive surgery with the LADAR 6000. Of those, 245 were submitted to photorefractive keratectomy (PRK) to correct a manifest spheroequivalent refractive error (MSRE) of -5.5+4.3 D, with a cylinder ranging from -4.50 to +3.50 D. Fifty-five eyes were submitted to LASIK using the Zyoptix XP microkeratome (Bausch & Lomb) to correct MSRE of -0.75 to -9.29 with a cylinder ranging from 0.00 to -5.50 D.

Following PRK, uncorrected visual acuity (UCVA) was 0.9, best spectacle corrected visual acuity (BSCVA) was 1.0 and MSRE was 0.00. The eyes which underwent LASIK reached a UCVA of 0.7, a BSCVA of 0.9 and a MSRE of 0.4. Just one eye lost two lines of BSCVA due to adenoviral keratoconjunctivitis.

Dr Murta concluded that the LADAR 6000 offers good results but is a time consuming procedure.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.